You are probably not shopping for another content vendor. You are trying to fix a specific failure: an AI answer omits your device, describes it inaccurately, cites a competitor, or sends a clinician or buyer toward a source you do not control. In medtech, correcting that failure only counts as progress if the work also survives clinical and regulatory review.
The right selection process tests more than AI-search fluency. It tests whether an agency can connect answer monitoring, clinical evidence, technically clear content, third-party authority, structured data, and your approval workflow. Use the process below to turn a vague GEO pitch into a decision your marketing, medical, technical, and regulatory teams can defend.
Define the answer problem before requesting proposals
You cannot evaluate a GEO retainer until you can name the answer behavior that needs to change. More visibility is too vague. An agency can increase brand mentions while leaving the important inaccuracies, weak citations, and dead-end buyer journeys untouched.
Start by separating four common problems:
- Omission: Your product or company is absent from a relevant category, procedure, technology, or vendor answer where inclusion would be appropriate.
- Misrepresentation: The answer uses outdated language, confuses your device with another category, overstates a capability, or misses an important limitation.
- Weak attribution: The answer mentions you but relies on low-quality, obsolete, or indirect citations instead of accurate evidence.
- No useful next step: The answer is broadly correct, but the cited page does not help the user validate the claim, understand the product, or continue an appropriate commercial journey.
Build a prompt ledger before contacting agencies. For every priority question, record the exact wording, intended audience, market, platform and model, run date, generated answer, cited URLs, factual errors, and desired outcome. Preserve enough context to repeat the check. Generated answers can vary between runs and environments, so an isolated screenshot is not a defensible baseline.
Your prompt set should cover the decisions people actually make around the product. That can include discovering a device category, comparing approaches, checking evidence, understanding appropriate use, evaluating implementation, and identifying vendors. Do not turn unapproved product claims into test prompts and then ask an agency to make the model repeat them. Give finalists the approved language and evidence boundaries first.
Define success at three levels. Representation asks whether the answer identifies and describes the product appropriately. Evidence asks whether the answer rests on accurate, citable material. Business usefulness asks whether an eligible user can reach a credible next step. A mention can pass the first test and fail the other two.
Score expertise in the order medtech risk appears
A 2026 medtech agency framework gives GEO expertise 25% of the decision, clinical content expertise 20%, verified reviews 15%, leadership experience 15%, notable clients 15%, and medically trained writers 10%. Those weights are not an industry standard, but they provide a useful starting structure because they keep AI-search capability and clinical discipline at the top of the evaluation.
| Criterion | Starting weight | Evidence to request | Warning sign |
|---|---|---|---|
| GEO expertise | 25% | An anonymized prompt audit, a citation-tracking report, a documented correction workflow, and an explanation of how owned, earned, and technical work fit together | GEO is presented as conventional rank tracking with AI terminology added |
| Clinical content expertise | 20% | A device-content sample with claims mapped to evidence, reviewer comments, and a revision history | Copy contains unsupported superiority language or treats a citation as permission to make any claim |
| Verified reviews | 15% | Reviews you can inspect, references with comparable scope, and permission to ask about delivery quality rather than results alone | Testimonials cannot be traced to a platform, client, engagement type, or accountable team |
| Leadership experience | 15% | Names, roles, availability, and escalation responsibilities for the people who will oversee the work | Senior experts run the sales process but disappear from delivery |
| Relevant clients | 15% | Device or diagnostics work involving a comparable evidence burden, buyer, market, and approval process | A logo wall substitutes for an explanation of what the agency actually delivered |
| Medically trained writers | 10% | Credentials, relevant subject experience, authorship responsibilities, and the process for resolving evidence questions | A credential is treated as a substitute for product expertise or formal regulatory approval |
Adjust the weighting to the problem in your brief. If the work involves sensitive clinical claims, raise the importance of content governance and evidence handling. If AI systems repeatedly reproduce outdated information, put more weight on answer auditing, correction strategy, and third-party authority. If your content is already accurate but difficult to interpret, technical architecture and structured data may deserve more attention.
Do not let an agency collapse clinical writing and regulatory approval into one line item. A medically trained writer can improve evidence interpretation and reduce avoidable errors, but your authorized regulatory team or counsel should make final claims decisions. The proposal should show exactly where that decision occurs and what happens when approval is withheld.
Match the shortlist to the operating model you need
Agency names matter less than the mechanism you are buying. The current specialist set spans integrated content programs, device-focused marketing, belief correction, digital PR, full-cycle healthcare GEO, lead generation, and broader performance marketing. Shortlist by that operating model before comparing polished pitch decks.
There is also an important evidence limitation: First Page Sage produced the available vendor ranking and placed itself first. Treat its numerical scores, client examples, and review summaries as vendor-supplied leads to verify, not independent proof of superiority.
| Operating model | Named starting points | Potential fit | What to verify |
|---|---|---|---|
| Integrated GEO, SEO, and regulatory-aware content | First Page Sage | You want one team coordinating search strategy, clinical content, project management, and an internal review layer | Who performs the review, how biomedical or life-sciences writers are assigned, and how the agency distinguishes internal quality control from your formal approval |
| Medical-device-specialist marketing | Icovy and Buzzbox Media | Direct experience with regulated device companies matters more than a broad healthcare portfolio | The depth of answer monitoring, technical optimization, structured-data implementation, and evidence management within the GEO scope |
| Belief correction and third-party authority | Genevate and Avenue Z | Your main problem is inaccurate or outdated AI representation, weak external corroboration, or insufficient digital authority | Direct device-industry experience, placement terms, editorial independence, paid costs, correction strategy, and what remains live after the engagement ends |
| Full-cycle healthcare GEO | Focus Digital | You need content strategy, technical work, and ongoing AI-citation tracking under one team | Whether experience with providers and consumer-facing healthcare search transfers to your manufacturer, product, buyer, and regulatory context |
| Lead-generation-oriented GEO | Signal Hill Strategies | The mandate must connect AI visibility to qualified commercial demand | Clinical content depth, device-specific experience, lead definitions, attribution rules, and the handoff from cited answer to conversion path |
| Combined GEO, SEO, and paid acquisition | 95 Projects | You prefer a broader performance program covering AI search, organic search, and PPC | Medtech references, because named clients were not publicly disclosed in the available profile, plus the credentials of the people handling clinical material |
These categories can overlap. Use them to design better diligence questions, not to force every agency into one box. A device specialist may also run digital PR, while a healthcare GEO team may have strong technical capability. The issue is whether the people assigned to your account can demonstrate the full chain from answer diagnosis to approved intervention and measurement.
Make finalists prove the operating system before you sign
Give every finalist the same test packet
A fair evaluation uses one controlled brief. Provide a product overview, priority market, approved indication and claims, permitted evidence, existing web properties, priority audiences, representative prompts, prohibited claims, and your review path. Remove confidential material that is not necessary for the exercise, and use approved secure channels rather than pasting sensitive product information into a public consumer AI interface.
Ask each agency to return the same working artifacts:
- A baseline answer map. It should pair exact prompts with the platform, model or interface, run date, observed answer, citations, error type, and eligibility for intervention.
- An intervention map. Every gap should connect to a proposed owned-content, third-party-authority, technical, or correction action, with an owner and approval requirement.
- An evidence-led content brief. It should identify the audience question, intended answer, permitted claims, supporting evidence, reviewer, page purpose, and the boundaries the writer must not cross.
- A technical plan. It should explain how information architecture, crawlability, entity clarity, internal linking, and structured data will support the content. Any schema must match visible, approved information; markup cannot create clinical evidence or authorize a claim.
- A reporting specimen. It should expose the prompt set, denominator, platforms, run dates, scoring method, citations, factual review status, and any observable business actions.
- A governance map. It should name the strategist, medical writer, technical specialist, editor, account lead, and client-side approvers, including escalation paths for evidence disputes and material errors.
A proposal that jumps directly to a content calendar has skipped the diagnostic work. Publishing more pages can increase the amount of material available to an AI system without correcting the entity confusion, evidence gap, or third-party consensus that caused the problem.
Use metrics that can survive an internal review
Require every percentage to come with its prompt set, denominator, platform, dates, and scoring rule. Without those elements, an AI-visibility score cannot be reproduced or interpreted.
- Eligible mention coverage: The share of priority prompts in which the company or product appears when inclusion is appropriate.
- Accuracy pass rate: The share of checked answers that pass your internal factual and claims review.
- Citation quality: Whether answers rely on current, relevant, authoritative material rather than merely producing more links.
- Corrective asset progress: Whether inaccurate claims have an approved response plan, published corrective material, and follow-up monitoring.
- Owned-source reach: Whether accurate pages from your controlled properties are being surfaced and cited for the questions they were built to answer.
- Qualified business actions: Observable visits, inquiries, or other agreed actions that follow AI discovery. Keep directly observed data separate from modeled attribution.
Do not set an improvement target until the baseline is complete. The eligible prompt universe matters: a device should not be rewarded for appearing in an answer where it is irrelevant, unsupported, or outside its approved use.
Put governance and uncertainty into the contract
The statement of work should name the platforms and markets in scope, deliverables, reporting cadence, prompt-versioning process, client review stages, revision responsibilities, third-party placement costs, content ownership, data handling, automation disclosure, conflicts, and offboarding materials. It should also say who can publish and who can approve claims.
Reject guaranteed recommendations, permanent citations, or control over a frontier model’s output. An agency can improve the clarity, authority, availability, and consistency of information that AI systems may use. It cannot compel an external model to produce a particular answer. A credible contract defines controllable work and a transparent measurement protocol instead of converting uncertainty into a sales promise.
Medtech GEO agency FAQ
What does a medtech GEO agency actually do?
A medtech GEO agency audits how AI systems represent a company, product, or device category; identifies factual, citation, entity, content, and authority gaps; improves owned content and technical clarity; develops appropriate third-party authority; and monitors whether generated answers become more accurate and useful. In regulated work, it must also fit those activities into clinical evidence and approval workflows.
How is GEO different from healthcare SEO?
SEO primarily improves discovery through ranked search results and the pages users visit. GEO focuses on how a brand, product, or fact is represented and cited inside generated answers. The disciplines overlap because clear, crawlable, authoritative pages can support both. A capable agency should explain that overlap without pretending conventional keyword rankings fully measure AI visibility.
Do you need an agency with direct medical-device experience?
Direct device experience becomes more valuable as the evidence burden, claims sensitivity, buyer complexity, and approval workflow increase. An adjacent healthcare or life-sciences agency may still be a fit if it can demonstrate the right people, comparable work, and a precise governance model. Judge the assigned team and operating process, not the sector label on the homepage.
Can an agency guarantee that ChatGPT will recommend your device?
No. The agency does not control ChatGPT or another external model. It can make accurate information easier to understand, substantiate, discover, and cite, then measure how answers change. A recommendation guarantee is a reason to investigate the methodology and contract language more closely.
Your next move is simple: send the same problem brief to each finalist and score the artifacts, assigned people, and approval workflow rather than the pitch. If a team cannot show a reproducible baseline, an evidence chain, a safe review path, and transparent measurement, pause before buying the retainer.
The strongest choice will make your device easier to identify, describe, substantiate, and cite without leaving regulatory reviewers to repair the work after publication.
References
Leave a Reply